Sreejana Basu

Sreejana Basu is an experienced professional currently involved in multiple roles within the biotech and healthcare sectors. At Nucleate, Sreejana serves on the Leadership Team for Dojo, focusing on empowering biotech innovators, and is also a researcher at Springer Healthcare, with a published focus on urological malignancies and antibody-drug conjugate therapies. As Vice President and Marketing Executive at UCL Entrepreneurs, Sreejana has been instrumental in various initiatives, including leading the inaugural UCL Changemakers project aimed at enhancing student learning experiences in Cancer Biomedicine. Additional contributions include organizing UCL’s National Undergraduate Oncology Conference and securing over £5000 for the Anti-Malaria Foundation through Raise UCL. Sreejana is pursuing a BSc in Cancer Biomedicine at UCL and has a background in the International Baccalaureate from Global Schools Group.